ESC Premium Access

Ten-year all-cause death in elderly patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A prespecified subgroup analysis of the SYNTAX Extended Survival study

Congress Presentation

About the speaker

Doctor Masafumi Ono

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

6 more presentations in this session

Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017

Speaker: Associate Professor M. Leosdottir (Malmo, SE)


Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach

Speaker: Professor R. Storey (Sheffield, GB)


Identifying high thrombotic risk in atrial fibrillation patients undergoing percutaneous coronary intervention: is there a benefit of triple therapy?

Speaker: Mr W. Bor (Nieuwegein, NL)


Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Speaker: Doctor T. Vanassche (Leuven, BE)


Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization in patients with stable ischemic heart disease

Speaker: Doctor S. Lee (Gwangju, KR)


Access the full session

Optimizing Management of Chronic CAD – Squeeze on Big Data for Additional Info

Speakers: Doctor M. Ono, Associate Professor M. Leosdottir, Professor R. Storey, Mr W. Bor, Doctor T. Vanassche...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb